Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Jensen

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 4, 2014
The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cellsYevgeniya Kushchayeva, Kirk Jensen, Antony Recupero, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2015
Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid CancerAthanasios Bikas, Douglas Van Nostrand, Kirk Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2013
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancerJoanna Klubo-Gwiezdzinska, John Costello, Aneeta Patel, et al.
Endocrine-Related Cancer|March 6, 2012
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cellsJoanna Klubo-Gwiezdzinska, Kirk Jensen, John Costello, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancersZhi Liu, Peng Hou, Meiju Ji, et al.
Endocrine Connections|August 10, 2017
Amifostine does not protect thyroid cancer cells in DNA damaging <i>in vitro</i> modelsJoanna Klubo-Gwiezdzinska, John Costello, Kirk Jensen, et al.
The Journal of Endocrinology|May 31, 2012
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stressJoanna Klubo-Gwiezdzinska, Kirk Jensen, Andrew Bauer, et al.
Cancers|April 13, 2024
Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid CancerLeila Shobab, Hui Zheng, Kirk Jensen, et al.
Frontiers in Oncology|October 18, 2019
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)Shilpa Thakur, Andrew Tobey, Brianna Daley, et al.
FEBS Letters|June 10, 2025
Validation of single-cell transcriptomic profiles from Illumina and MGI Tech sequencing platformsValerie Vandenbempt, Michael Roach, Monika Mohenska, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|February 4, 2014
The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cellsYevgeniya Kushchayeva, Kirk Jensen, Antony Recupero, et al.
Thyroid : Official Journal of the American Thyroid Association|December 10, 2015
Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid CancerAthanasios Bikas, Douglas Van Nostrand, Kirk Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2013
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancerJoanna Klubo-Gwiezdzinska, John Costello, Aneeta Patel, et al.
Endocrine-Related Cancer|March 6, 2012
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cellsJoanna Klubo-Gwiezdzinska, Kirk Jensen, John Costello, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancersZhi Liu, Peng Hou, Meiju Ji, et al.
Endocrine Connections|August 10, 2017
Amifostine does not protect thyroid cancer cells in DNA damaging <i>in vitro</i> modelsJoanna Klubo-Gwiezdzinska, John Costello, Kirk Jensen, et al.
The Journal of Endocrinology|May 31, 2012
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stressJoanna Klubo-Gwiezdzinska, Kirk Jensen, Andrew Bauer, et al.
Cancers|April 13, 2024
Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid CancerLeila Shobab, Hui Zheng, Kirk Jensen, et al.
Frontiers in Oncology|October 18, 2019
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)Shilpa Thakur, Andrew Tobey, Brianna Daley, et al.
FEBS Letters|June 10, 2025
Validation of single-cell transcriptomic profiles from Illumina and MGI Tech sequencing platformsValerie Vandenbempt, Michael Roach, Monika Mohenska, et al.
Pageof 4